Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anti-inflammatory and central nervous system (CNS) active compounds. Its structure supports the design of molecules with enhanced metabolic stability and binding affinity due to the presence of the trifluoromethyl group. Commonly employed in medicinal chemistry for optimizing drug candidates targeting neurological disorders and chronic pain. Also utilized in research settings to explore new bioactive heterocycles.